These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 15857307

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.
    Evans M, Roberts A, Davies S, Rees A.
    Drugs; 2004; 64(11):1181-96. PubMed ID: 15161326
    [Abstract] [Full Text] [Related]

  • 3. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
    Cziraky MJ, Watson KE, Talbert RL.
    J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pitavastatin: novel effects on lipid parameters.
    Chapman MJ.
    Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Squalene synthase inhibitors : clinical pharmacology and cholesterol-lowering potential.
    Charlton-Menys V, Durrington PN.
    Drugs; 2007 Nov; 67(1):11-6. PubMed ID: 17209661
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Novel agents to manage dyslipidemias and impact atherosclerosis.
    Nachimuthu S, Raggi P.
    Cardiovasc Hematol Disord Drug Targets; 2006 Sep; 6(3):209-17. PubMed ID: 17017903
    [Abstract] [Full Text] [Related]

  • 11. Pitavastatin: an overview.
    Saito Y.
    Atheroscler Suppl; 2011 Nov; 12(3):271-6. PubMed ID: 22152281
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cerivastatin: a review of its pharmacological properties and therapeutic efficacy in the management of hypercholesterolaemia.
    Plosker GL, Dunn CI, Figgitt DP.
    Drugs; 2000 Nov; 60(5):1179-206. PubMed ID: 11129127
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Other therapies for reducing low-density lipoprotein cholesterol: medications in development.
    Stein EA.
    Endocrinol Metab Clin North Am; 2009 Mar; 38(1):99-119. PubMed ID: 19217514
    [Abstract] [Full Text] [Related]

  • 17. HMG-CoA reductase inhibition: anti-inflammatory effects beyond lipid lowering?
    März W, Köenig W.
    J Cardiovasc Risk; 2003 Jun; 10(3):169-79. PubMed ID: 12775949
    [Abstract] [Full Text] [Related]

  • 18. [Treatment of high blood cholesterol in patients with coronary heart disease].
    Nagai Y, Yamashita S.
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():675-81. PubMed ID: 12735049
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Identifying patients at risk for coronary heart disease: implications from trials of lipid-lowering drug therapy.
    Isles CG, Paterson JR.
    QJM; 2000 Sep; 93(9):567-74. PubMed ID: 10984551
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.